World News

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

Ogkologos - 6 Δεκεμβρίου, 2023

Sotorasib in Combination with Panitumumab Results in Longer PFS in Patients...

Ogkologos - 6 Δεκεμβρίου, 2023

How Joining a Clinical Trial Helped Me Find Hope While Living...

Ogkologos - 5 Δεκεμβρίου, 2023

Neoadjuvant Toripalimab Combined with Axitinib Demonstrates a Promising Pathologic Response Rate...

Ogkologos - 5 Δεκεμβρίου, 2023

First Study to Demonstrate that PD1 Immune Checkpoint Blockade May Yield...

Ogkologos - 4 Δεκεμβρίου, 2023

Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer

Ogkologos - 1 Δεκεμβρίου, 2023

EMA Recommends Extending Indications for Pembrolizumab to Patients with Advanced Biliary...

Ogkologos - 1 Δεκεμβρίου, 2023

Learning to Live With Cancer: A Survivor’s Story

Ogkologos - 30 Νοεμβρίου, 2023

Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder...

Ogkologos - 30 Νοεμβρίου, 2023

FDA Amends Indication for Pembrolizumab in the First-Line Treatment for Patients...

Ogkologos - 30 Νοεμβρίου, 2023

1...100101102...432 Σελίδα 101 από 432

MOST POPULAR

Disease in a dish: Mini-gut organoids and the challenges of bowel...

11 Φεβρουαρίου, 2022

Should People with Cancer and Cancer Survivors Get the Flu Vaccine?

2 Σεπτεμβρίου, 2020

Patient Guide in Testicular Cancer Now Available Also in French

1 Δεκεμβρίου, 2025

Survivors of Childhood Cancer are at Excess Risk of Late Mortality...

21 Απριλίου, 2023

Φόρτωση περισσοτέρων

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

Sotorasib in Combination with Panitumumab Results in Longer PFS in Patients...

How Joining a Clinical Trial Helped Me Find Hope While Living...

Neoadjuvant Toripalimab Combined with Axitinib Demonstrates a Promising Pathologic Response Rate...

First Study to Demonstrate that PD1 Immune Checkpoint Blockade May Yield...

Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer

EMA Recommends Extending Indications for Pembrolizumab to Patients with Advanced Biliary...

Learning to Live With Cancer: A Survivor’s Story

Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder...

FDA Amends Indication for Pembrolizumab in the First-Line Treatment for Patients...

MOST POPULAR

Disease in a dish: Mini-gut organoids and the challenges of bowel...

Should People with Cancer and Cancer Survivors Get the Flu Vaccine?

Patient Guide in Testicular Cancer Now Available Also in French

Survivors of Childhood Cancer are at Excess Risk of Late Mortality...

HOT NEWS

The Lung Immune Prognostic Index May Indicate Response to Immune Checkpoint...

Courageous children receive Star Awards in virtual celebration

FDA Approves Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer

How to Be Brave When Your Parent Has Cancer: A Kid’s...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ